Scinovex
Subscribe
A

Aalok Shah

Ifm Therapeutics (United States) (US)ORCID 0000-0001-5601-088X
h-index
6
Publications
14
Citations
1.8K
i10-index
6
Impact (2-yr)
—
Citations per year
Research Areas
RNA Interference and Gene DeliveryGlycosylation and Glycoproteins ResearchCRISPR and Genetic EngineeringAdvanced biosensing and bioanalysis techniquesShoulder Injury and Treatment
Affiliations
Northeastern University
US · 2010–2010
Hofstra University
US · 2018–2018
Emory University
US · 1998–1998
Ifm Therapeutics (United States)
US · 2023–2023
Intellia Therapeutics (United States)
US · 2018–2018
Dicerna Pharmaceuticals (United States)
US · 2013–2013
Beam Therapeutics (United States)
US · 2020–2022
B.J. Medical College
IN · 2020–2020

Top Publications

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Cell Reports2018810 citations
Retrospective study of open tibial diaphyseal fractures type IIIA and IIIB by Ilizarov method
International Journal of Orthopaedics Sciences20171 citations